scispace - formally typeset
J

John A. Hanover

Researcher at National Institutes of Health

Publications -  179
Citations -  12940

John A. Hanover is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Nuclear pore & Glycosylation. The author has an hindex of 54, co-authored 164 publications receiving 11840 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

The superhelical TPR-repeat domain of O-linked GlcNAc transferase exhibits structural similarities to importin alpha.

TL;DR: The crystal structure of the homodimeric TPR domain of human OGT, which contains 11.5 TPR repeats, is solved and it is proposed that OGT uses an analogous molecular mechanism to recognize its targets.
Journal ArticleDOI

Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase

TL;DR: The differential localization of mitochondrial and nucleocytoplasmic isoforms of OGT suggests that they perform unique intracellular functions.
Journal ArticleDOI

MLN64 Mediates Mobilization of Lysosomal Cholesterol to Steroidogenic Mitochondria

TL;DR: It is concluded that MLN64 participates in mobilization and utilization of lysosomal cholesterol by virtue of the START domain's role in cholesterol transport.
Journal ArticleDOI

Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer

TL;DR: The knockout of O-GlcNAcase (oga-1) in C. elegans mimics many of the metabolic and signaling changes associated with human insulin resistance and provides a genetically amenable model of non-insulin-dependent diabetes.